Potential mechanism for BCG vaccine reversal of type 1 diabetes
Saturday, June 10, 2017 - 15:21
in Health & Medicine
Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guérin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas.